Covered recipient · General Payments record
MICHAL GERBLICH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$4,558.34
- Reported across 255 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $948.42 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $443.29 | 20 |
| Novo Nordisk AS | $250.00 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $136.74 | 2 |
| IRONWOOD PHARMACEUTICALS, INC | $57.26 | 2 |
| Ardelyx, Inc. | $45.17 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.18 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164109 | CMS |
| ABBVIE INC. | $20.36 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164111 | CMS |
| ABBVIE INC. | $20.22 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164113 | CMS |
| ABBVIE INC. | $9.80 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164115 | CMS |
| ABBVIE INC. | $5.76 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164117 | CMS |
| ABBVIE INC. | $21.53 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164119 | CMS |
| ABBVIE INC. | $13.34 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164121 | CMS |
| ABBVIE INC. | $16.88 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164123 | CMS |
| ABBVIE INC. | $23.13 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164125 | CMS |
| ABBVIE INC. | $7.64 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164127 | CMS |
| ABBVIE INC. | $23.08 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164129 | CMS |
| ABBVIE INC. | $21.80 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164131 | CMS |
| ABBVIE INC. | $7.74 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164133 | CMS |
| ABBVIE INC. | $21.30 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164135 | CMS |
| ABBVIE INC. | $15.82 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164137 | CMS |
| ABBVIE INC. | $15.78 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164139 | CMS |
| ABBVIE INC. | $22.11 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164141 | CMS |
| ABBVIE INC. | $20.62 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164143 | CMS |
| ABBVIE INC. | $15.20 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164145 | CMS |
| ABBVIE INC. | $125.00 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107164147 | CMS |
| Ardelyx, Inc. | $17.46 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146727818 | CMS |
| Ardelyx, Inc. | $27.71 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146727820 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $27.99 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153714343 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $29.27 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153740591 | CMS |
| Novo Nordisk Inc | $125.00 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100382181 | CMS |
| Novo Nordisk Inc | $125.00 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100558855 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $125.00 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153471169 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $11.74 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153587416 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.96 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137752623 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.